Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

NCT05809024 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Breast Cancer
Hormone Receptor Positive，HER2-negative Breast Cancer

Interventions

DRUG: letrozole

Sponsor

Yongsheng Wang

Collaborators

[object Object]